Was your drink spiked? One Providence College student is creating a new straw that could warn you.
Some research shows that more than
Get Rhode Map
A weekday briefing from veteran Rhode Island reporters, focused on the things that matter most in the Ocean State.
Enter Email
Sign Up
Neve Palmeri presents her idea for SmartSip at the Donald Ryan Incubator Elevator Pitch Competition at Providence College in November 2024.
Providence College
Advertisement
Q: What is SmartSip, and how does it work?
Palmeri:
Smart Sip will be a reusable, plastic drug-detecting straw. You put it in your drink, and if there is date-rape drugs — which primarily consists of roofies, ketamine, and GHB — then the straw will change colors, letting you know that your drink is unsafe to drink.
Explain the science.
Basically, we're using silver nanoclusters bound to DNA to bind the drugs. Our research has shown that ketamine will react by binding to these colored silver-DNA nanoclusters and quench their color. Our straws will be fluorescent, and if your drink is spiked, the straw will turn clear.
So for now, it's only going to react to ketamine?
Just ketamine now. We plan to do a feasibility study, and then we will be able to scale that detection to other drugs.
How did you come up with the idea?
When my cousin was in Aruba, her drink was spiked. She was unconscious for many hours. And then when I started to talk about my idea and pitch it, I learned how common this really was. I'm in college myself, and I think it's a pervasive problem that we don't really have any solution to.
Advertisement
These drugs don't have a color, odor, or taste, which makes them really impossible to detect. Plus, they are only traceable within the bloodstream for the first few hours.
This also happened to one of my roommates. He went to the hospital after his drink was laced, and they said they could not even test him because it was no longer traceable within your bloodstream
.
One of my roommate's mothers said this happened to her 35 years ago. She's interested in my idea because when she was telling her daughter what happened to her all those years ago, she couldn't even give a concrete solution to the problem.
Related
:
Do you have a patent?
I'm still in the patent provisional stage, so we're still testing that science
.
What challenges did you face while developing SmartSip, especially as someone without a chemistry background?
I'm a management and marketing major. Without the chemistry knowledge, I didn't know if this was actually going to be feasible. So I've been working with chemistry faculty at Providence College mainly. I have one chemistry adviser who has really worked on the science side of the product.
My next challenge is finding chemistry students who are interested enough in my straw to work on a summer research grant this summer. I am also working on identifying a manufacturer.
What are your plans to bring SmartSip to market?
My go-to market strategy would be selling to colleges first. There are 18 million students in college and 197 million people over the age of 21 in the US. There are existing health and safety budgets within those colleges, so I should be able to easily integrate this product into their offerings to students.
Advertisement
Selling to nightclubs, bars, and restaurants that surround these institutions could be the second step. But I've also discovered that some alcohol brands have safety initiatives and budgets as well. I could partner with them.
Selling directly to the consumer could be a strategy too, targeting women aged 21 to 40 who have active social lives.
Who is your competition?
There's
There's also two other competitors: One is a coaster and wristband. But both require you to take a sample of your drink and place it on that tech. It's not a seamless integration. It's taxing and not very realistic.
Do you have investors?
I've won $7,000 in awards altogether from pitch competitions. Now I'm applying for some research grants. Besides that funding, the next steps are finding investors.
How much will they cost to make, and what will you charge?
We've priced them at $7.50 each right now, and we've estimated that we can produce them for around $1.25 each. We intend to make them in the United States.
Advertisement
The Boston Globe's weekly Ocean State Innovators column features a Q&A with Rhode Island innovators who are starting new businesses and nonprofits, conducting groundbreaking research, and reshaping the state's economy. Send tips and suggestions to reporter Alexa Gagosz at
.
Alexa Gagosz can be reached at
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Boston Globe
03-06-2025
- Boston Globe
Boston 10K pro field to feature Boston Marathon champion Sharon Lokedi, American Olympians
'Winning the Boston Marathon is a highlight of my career so far,' said Lokedi in a release. 'I'm excited to return to Boston to race the 10K and relive the same feeling from the marathon.' Lokedi will be joined in the women's pro field by another Boston Marathon champion, Edna Kiplagat, as well as a pair of American Olympic marathoners, Providence College alum Emily Sisson and 2024 US Olympic Marathon Trials winner Fiona O'Keeffe. Advertisement American Olympians Emily Sisson (left) and Fiona O'Keeffe (center) will race the Boston 10K this month. Mike Ehrmann/Getty The stacked women's field also features 2024 New York City Marathon champion Sheila Chepkirui (who boasts the fastest personal best in the field at 29:46), as well as The women's wheelchair field will be led by four-time Boston Marathon and five-time Boston 10K champion Tatyanna McFadden. Two-time Boston Marathon champion Daniel Romanchuk will headline the men's wheelchair race. The men's professional field is loaded with depth, with Tanzania's Gabriel Geay — event winner in 2018 and 2023, as well as Boston Marathon runner-up in 2023 — among the biggest names on the start list. Joe Klecker, an Olympian over 10,000 meters in 2021, will lead the American charge. Kenya's Dennis Kitiyo has the fastest personal best in the field at 27:01. Advertisement 'The Boston 10K annually brings together some of the fastest and most competitive athletes from around the globe,' said Mary Kate Shea, the BAA's senior director of professional athletes. 'The Boston running community can expect fast times and thrilling races at this year's 10K across all divisions.' Around 10,000 athletes are expected to race on June 22, with the course winding through Cambridge and the Back Bay. The route begins on Charles Street and crosses the Longfellow Bridge for an out-and-back and Memorial Drive before crossing back over the Harvard Bridge on Massachusetts Avenue. Runners will then loop through Kenmore Square, make the right on Hereford and left onto Boylston, finishing between the Boston Common and Public Garden. Amin Touri can be reached at
Boston Globe
31-03-2025
- Boston Globe
Was your drink spiked? One Providence College student is creating a new straw that could warn you.
Some research shows that more than Get Rhode Map A weekday briefing from veteran Rhode Island reporters, focused on the things that matter most in the Ocean State. Enter Email Sign Up Neve Palmeri presents her idea for SmartSip at the Donald Ryan Incubator Elevator Pitch Competition at Providence College in November 2024. Providence College Advertisement Q: What is SmartSip, and how does it work? Palmeri: Smart Sip will be a reusable, plastic drug-detecting straw. You put it in your drink, and if there is date-rape drugs — which primarily consists of roofies, ketamine, and GHB — then the straw will change colors, letting you know that your drink is unsafe to drink. Explain the science. Basically, we're using silver nanoclusters bound to DNA to bind the drugs. Our research has shown that ketamine will react by binding to these colored silver-DNA nanoclusters and quench their color. Our straws will be fluorescent, and if your drink is spiked, the straw will turn clear. So for now, it's only going to react to ketamine? Just ketamine now. We plan to do a feasibility study, and then we will be able to scale that detection to other drugs. How did you come up with the idea? When my cousin was in Aruba, her drink was spiked. She was unconscious for many hours. And then when I started to talk about my idea and pitch it, I learned how common this really was. I'm in college myself, and I think it's a pervasive problem that we don't really have any solution to. Advertisement These drugs don't have a color, odor, or taste, which makes them really impossible to detect. Plus, they are only traceable within the bloodstream for the first few hours. This also happened to one of my roommates. He went to the hospital after his drink was laced, and they said they could not even test him because it was no longer traceable within your bloodstream . One of my roommate's mothers said this happened to her 35 years ago. She's interested in my idea because when she was telling her daughter what happened to her all those years ago, she couldn't even give a concrete solution to the problem. Related : Do you have a patent? I'm still in the patent provisional stage, so we're still testing that science . What challenges did you face while developing SmartSip, especially as someone without a chemistry background? I'm a management and marketing major. Without the chemistry knowledge, I didn't know if this was actually going to be feasible. So I've been working with chemistry faculty at Providence College mainly. I have one chemistry adviser who has really worked on the science side of the product. My next challenge is finding chemistry students who are interested enough in my straw to work on a summer research grant this summer. I am also working on identifying a manufacturer. What are your plans to bring SmartSip to market? My go-to market strategy would be selling to colleges first. There are 18 million students in college and 197 million people over the age of 21 in the US. There are existing health and safety budgets within those colleges, so I should be able to easily integrate this product into their offerings to students. Advertisement Selling to nightclubs, bars, and restaurants that surround these institutions could be the second step. But I've also discovered that some alcohol brands have safety initiatives and budgets as well. I could partner with them. Selling directly to the consumer could be a strategy too, targeting women aged 21 to 40 who have active social lives. Who is your competition? There's There's also two other competitors: One is a coaster and wristband. But both require you to take a sample of your drink and place it on that tech. It's not a seamless integration. It's taxing and not very realistic. Do you have investors? I've won $7,000 in awards altogether from pitch competitions. Now I'm applying for some research grants. Besides that funding, the next steps are finding investors. How much will they cost to make, and what will you charge? We've priced them at $7.50 each right now, and we've estimated that we can produce them for around $1.25 each. We intend to make them in the United States. Advertisement The Boston Globe's weekly Ocean State Innovators column features a Q&A with Rhode Island innovators who are starting new businesses and nonprofits, conducting groundbreaking research, and reshaping the state's economy. Send tips and suggestions to reporter Alexa Gagosz at . Alexa Gagosz can be reached at
Yahoo
21-11-2024
- Yahoo
Most, but not all, Rhode Island hospitals get good report cards from national ranking group
Rhode Island Hospital receives a B grade in the Leapfrog Group's biannual hospital safety grades. The grade is an improvement after a series of C's from the nonprofit. (Alexander Castro/Rhode Island Current) Four Rhode Island hospitals — Newport, Miriam, South County and Westerly — received top marks in the fall report from Leapfrog Group, a nonprofit that grades hospitals on safety. The Washington, D.C.-based Leapfrog assigns hospitals letter grades based on data from the Centers for Medicare & Medicaid Services (CMS) as well as Leapfrog's own surveys. Rhode Island's hospitals didn't perform much differently than they did in spring 2024 (The Miriam and Newport have consistently earned A's the past two years), with two notable exceptions. Westerly's A is its first since 2022. Landmark Medical Center in Woonsocket, which has received nine consecutive A grades, dropped to a B. Kent Hospital and Rhode Island Hospital also received B grades. The embattled Our Lady of Fatima Hospital and Roger Williams Medical Center both earned C grades. Rhode Island's hospitals collectively ranked seventh nationwide. South County Hospital's good report card was a boon to Dr. Kevin Charpentier, the vice president and chief medical officer at South County Health, the hospital's parent company. 'It's more than a score — it's a promise to our community of prioritizing the highest level of patient care,' Charpentier wrote in an email. The score was also a bit of good news amid an ongoing dispute between the hospital's administration and its staff. A September letter sent by doctors and nurses to the South County Health's board of trustees detailed escalating tensions between providers and management, with doctor resignations, service cuts and growing patient backlogs among the signatories' concerns. Landmark's B left its CEO Mike Souza disappointed. 'We take quality very seriously and our team has already put plans in place to address the areas needing improvement,' Souza said in an emailed response to Rhode Island Current. 'Our community will continue to receive great care and our expectation is that we will return to an 'A' grade in the near future.' Leapfrog aggregates 30 metrics to assess how well hospitals care for patients as well as prevent bad outcomes, like infections and falls. The grades are given to roughly 3,000 hospitals, not including VA hospitals or children's hospitals. Hospitals that lack enough data for multiple metrics are also excluded. Lisa P. Tomasso, senior vice president of the Hospital Association of Rhode Island, said via email that the trade group was pleased with the state's performance. But she added that the grades, while insightful, are 'not comprehensive, as they exclude factors like social determinants of health, community-level health challenges, and systemic issues like Medicaid reimbursement rates.' But grades still hold value. Robert Hackey, a professor of health sciences at Providence College, said that 'hospitals that don't do well tend to poke holes in whatever rating methodology that's used.' 'If you look at the hospitals in Rhode Island, for the most part, we're performing very well,' Hackey said. 'Yeah, we obviously have two low performers. It's Fatima and Roger Williams. And there's a common thread there. They're both owned by Prospect and they're both for-profit institutions, yeah. And they both struggle.' A representative for CharterCARE Health Partners, the Rhode Island subsidiary for Prospect Medical Holdings, which owns Roger Williams Medical Center and Our Lady of Fatima Hospital, did not respond to requests for comment. Facing growing debt, Prospect has sought to unload many of the hospitals in its portfolio, including the two safety net hospitals in Rhode Island. A proposal to sell Roger Williams and Fatima to a new, nonprofit owner, received conditional approval from state regulators in June, but the status of financing required to complete the transaction is unclear. Hackey said it's a bad sign when hospitals ignore questions on Leapfrog's survey — something both Fatima and Roger Williams Medical Center did when it came to inquiries about nursing and leadership. Our Lady of Fatima Hospital's 'C' grade is indicative of ongoing quality issues at Prospect Medical Holdings' hospitals in Rhode Island, says Providence College Professor Robert Hackey. (Michael Salerno/Rhode Island Current) Meanwhile hospitals owned by the state's largest health care system — Brown University Health, formerly Lifespan Corporation — all performed well. Rhode Island Hospital, the state's flagship hospital, received a B grade despite demonstrating below-average prevention rates of blood and urinary tract infections and falls causing broken hips, as well as less-than-stellar marks for hospital leadership and communication about medicines with patients. Since 2021, Rhode Island Hospital has received C grades more often than not. The B is evidence that things are improving, said Dr. Dean Roye, senior vice president for medical affairs and chief medical officer at the hospital. The Leapfrog grades 'help us pinpoint areas' to work on, Roye said. He added that a reorganization of quality and safety departments across Brown Health's properties was another factor in Rhode Island Hospital's improved grade. But Hackey is eyeing another Brown property, the A-graded Miriam, for a surgery he has scheduled for December. He explained with a laugh that checking the Leapfrog ratings was one of the first things he did when deciding where to have his surgery. 'The goal of this is to have a more educated healthcare consumer,' he said. Above average results Leapfrog uses the percentage of A grade hospitals in a state to determine a state's national ranking. Almost 61% of Utah's hospitals received A grades, giving it the top slot nationwide. The top 10 states all sported at least 40% A grade hospitals. An A grade indicates hospitals that prioritize safety, said Alex Campione, program analyst for the Leapfrog Group, who noted that about 32% of hospitals nationwide achieved this grade. Rhode Island was over the national average with 44% of its hospitals receiving an A grade. 'Each year more than 250,000 people will die in hospitals due to preventable errors, injuries, accidents, and infections,' Campione said. 'We estimate that, at the very least, 50,000 of those lives could be saved if all hospitals performed like A hospitals.' Rhode Island placed fourth nationwide in Leapfrog's spring 2024 scores, also with 44% at an A grade, but it was pushed out of the top five this time around by three states that rose with higher grades: California, North Carolina and Connecticut. Connecticut was the only other New England state to crack the top 10. Vermont fared worst of all, and was ranked 48th nationwide, tying for last place with North Dakota, South Dakota and Iowa. There was not a single A grade hospital in any of these states. Grading the graders But a bad report card might not be the final word on a hospital's quality. A 2019 article in New England Journal of Medicine Catalyst graded the graders, and gave Leapfrog a C-, the second lowest of the four systems reviewed. The study noted that Leapfrog had a detailed framework for measurement, with a unique focus on the hospitals' 'culture of safety.' But it also relied on its proprietary survey for a good chunk of its data — a problem, the authors thought, since Leapfrog grades hospitals the same regardless of whether they complete the survey. Dr. Karl Bilimoria of the Indiana University School of Medicine, who chairs the school's surgery department and leads its Surgical Outcomes and Quality Improvement Center, led the 2019 study. He wrote in an email Tuesday to Rhode Island Current that Leapfrog's efforts still leave something to be desired. 'Leapfrog has many issues with their methodology and their general approach that persist and they have been the least receptive to improvement suggestions and the least adaptive to changes in the science of quality measurement,' Bilimoria wrote. Asked about Bilimoria's idea that Leapfrog is not responsive to suggestions, spokesperson Lula Hailesilassie said by email that the public is regularly invited to submit feedback on proposed changes to its surveys. Comments on the 2025 survey are open through Dec. 13, 2024. SUBSCRIBE: GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX
